Investigator: Neal Kleiman, MD

Study Coordinator: Lisa Green

Status: Open Not Enrolling Number: NCT01614652

Phone: 713.441.3100

IRB Number: Pro00008214


The primary objective of the combined Phase I&II is to evaluate the reasonable assurance of safety and effectiveness of the CKI Parachute implant in the treatment of patients with NYHA Class III or IV(AMBULATORY) heart failure due to ischemic heart disease.
More to Explore